/ Glenmark Pharma Witnesses Biggest Intraday Fall In 7 Years ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Friday, 12 May 2017

The pharma stocks have been trading lower in the Friday’s trading session. Nifty pharma index is trading lower by 1.58% at 10017.6 level as of 0924 hours on Friday.

Despite the good quarterly financial results on a Y-o-Y basis, the Glenmark Pharma stock is the top loser in the pharma bunch on Friday morning. Investors have been finding the answers for what is happening with the Glenmark’s US business since the pricing pressure continues under the Trump administration in the US pharma sector.

Recently, the Glenmark Pharma consolidated revenue for the quarter came in at Rs 2457 crore, registering 6.5% Y-o-Y increase. EBITDA for the quarter rose by 46.2% Y-o-Y to Rs. 443.6 crore with a corresponding margin expansion of 489 bps. EBITDA margin for the quarter stood at 18.1%. The profit after tax (PAT) for the quarter came in at Rs. 183.7 crores, YoY increase of 23.5%.

The other pharma stocks like Cadila Healthcare, Aurobindo, Lupin, Divi’s Laboratories, PEL and Cipla are also trading in negative territory in the morning hours on Friday.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717